gvtcx

Provision of Clinical Trial Monitoring to the FaR-RMS Trial

key details

Statusactive
Category (CPV) 73300000 +2 more
RegionWest Midlands
Deadline30 Apr 2021
Procedureopen
OCIDocds-h6vhtk-02a184

description

The FaR-RMS trial The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
31 Mar 2021 Contract notice (F02) Earlier regulations 006675-2021

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.